Skip to main content
. 2018 Feb 27;3(2):2396–2405. doi: 10.1021/acsomega.7b02022

Figure 5.

Figure 5

AFM images of the modified nanodrug carriers of nGO. (a, a1) AFM image of pGO (nGO modified with 4-br-PEG-NH2), (a2) height profiles of line scannings in (a1); (b, b1) AFM image of pGO modified by FA and (b2) height profiles of line scannings in (b1); and (c, c1) AFM image of pGO-FA loaded with PTX and (c2) height profiles of line scannings in (c1).